Michael J. Fox joins Harrison Ford on season 3 of ‘Shrinking.’ Michael J. Fox joins 'Shrinking' season 3, returning to TV after retirement. Fox and Ford's characters both have Parkinson’s; they ...

Treatment is best when begun early and, like with many autoimmune diseases, when it is designed to reduce the immune system’s attacks on the body. This may include corticosteroi ...

In 1981, a strange arcade game appeared in Portland. Then kids got sick—seizures, hallucinations, even memory loss. And then the game vanished. The legend of Polybius became infamous, but hidden in ...

Emerging data show that many patients with drug-resistant epilepsy may be slipping through the cracks of standard clinical care, with an estimated 11% meeting criteria for drug-resistant epilepsy yet ...

Artificial intelligence has advanced rapidly, yet AI hallucinations remain a significant challenge. These occur when models generate convincing but incorrect content, like fictitious events or ...

Researchers at the UC Davis Department of Chemistry and Institute for Psychedelics and Neurotherapeutics have come up with a new technique to create candidate drugs that engage the serotonin receptor ...

Please provide your email address to receive an email when new articles are posted on . Of 200 videos, 78 were true, 67 were inaccurate, and 21 were potentially harmful. Physicians created 27 videos, ...

AI hallucinations are one of the most serious challenges facing generative AI today. These errors go far beyond minor factual mistakes. In real-world deployments, hallucinations have led to incorrect ...

A new study suggests temporal lobe epilepsy may be linked to early aging of certain brain cells. When researchers removed these aging cells in mice, seizures dropped, memory improved, and some animals ...

AI hallucinations about a brand come in many types: A generative AI system might show a person who isn’t the actual founder, display the wrong address for the headquarters, or describe an old product ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Semaglutide was associated with the strongest risk reduction. Epilepsy is an underrecognized ...